The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 study of tarloxotinib bromide (TRLX) in patients (pts) with EGFR-Mutant, T790M-Negative NSCLC progressing on an EGFR TKI.
 
Stephen V. Liu
Consulting or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Genentech; Perthera
 
Charu Aggarwal
Consulting or Advisory Role - Celgene (I); Genentech; Genentech (I)
Speakers' Bureau - Genentech (I); Novartis (I); Pfizer (I)
Research Funding - Genentech/Roche (Inst); Millennium (Inst); Nektar (Inst)
 
Christina Brzezniak
No Relationships to Disclose
 
Robert Charles Doebele
Honoraria - AstraZeneca; Clovis Oncology; Loxo; OxOnc; Pfizer
Consulting or Advisory Role - Array BioPharma; Lilly; Loxo; OxOnc; Pfizer; Pfizer
Research Funding - Abbott Molecular; Loxo; Mirati Therapeutics
Patents, Royalties, Other Intellectual Property - Licensing Fees for Biologic Material from Ariad (Inst); Licensing Fees for Biologic Material from Blueprint Medicines (Inst); Licensing Fees for Biologic Material from Chugai (Inst); Licensing Fees for Biologic Materials from GVKbio; Licensing Fees for Biologic Materials from Loxo Oncology (Inst); Licensing Fees from Abbott Molecular for Patent PCT/US2013/057495
Travel, Accommodations, Expenses - Ignyta
 
David E. Gerber
Stock and Other Ownership Interests - Gilead Sciences
Research Funding - ArQule (Inst); BerGenBio (Inst); Celgene (Inst); Genentech (Inst); ImClone Systems (Inst); Immunogen (Inst); Synta (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Decision Support in Medicine from the Clinical Decision Support--Oncology on-line program.; Royalties from Oxford University Press from two books.
Travel, Accommodations, Expenses - ArQule; Lilly; Lilly
 
Barbara Gitlitz
Consulting or Advisory Role - Clovis Oncology
Speakers' Bureau - Genentech; Lilly
Research Funding - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; novartis; Xcovery
 
Leora Horn
Honoraria - Biodesix
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Merck; Xcovery
Research Funding - AstraZeneca (Inst)
 
Benjamin J. Solomon
Honoraria - AstraZeneca; Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb (Inst); Eisai; Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Research Funding - Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Veristrat (Biodesix)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck; Roche
 
Tom Stinchcombe
Consulting or Advisory Role - Abbvie; Ariad; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene
Research Funding - Bristol-Myers Squibb; EMD Serono; Genentech; Merck; Threshold Pharmaceuticals
 
Liza Cosca Villaruz
No Relationships to Disclose
 
Howard Jack West
Honoraria - Celgene; Foundation Medicine; Genentech/Roche; Merck; Novartis; Pfizer
Consulting or Advisory Role - Celgene; Foundation Medicine; Genentech/Roche; Merck; Novartis; Pfizer
Travel, Accommodations, Expenses - Celgene; Foundation Medicine; Genentech/Roche; Merck; Novartis; Novartis
 
Stew Kroll
Employment - Threshold Pharmaceuticals
Stock and Other Ownership Interests - Threshold Pharmaceuticals
 
Tillman E. Pearce
Employment - Threshold Pharmaceuticals
Stock and Other Ownership Interests - Threshold Pharmaceuticals
 
D. Ross Camidge
No Relationships to Disclose